Loading company details...
Beta
Latest Form 4 (Apr 22, 2024): Thomas Braxton King (Director): Grant/Award of 3,110 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 22, 2024 | Thomas Braxton King | Grant/Award | 3,110 | n/a |
| Apr 22, 2024 | Michael A. Patane | Grant/Award | 3,556 | n/a |
| Apr 22, 2024 | Catherine Chai-Zon Lee | Grant/Award | 3,556 | n/a |
| Apr 22, 2024 | Robert S. Mills | Grant/Award | 4,667 | n/a |
| Apr 22, 2024 | Brandi Roberts | Grant/Award | 5,333 | n/a |
| Apr 22, 2024 | Kirk Allen Coleman, Chief Financial Officer | Grant/Award | 5,300 | n/a |
| Apr 22, 2024 | Zamaneh Mikhak, Chief Medical Officer | Grant/Award | 5,300 | n/a |
| Apr 22, 2024 | Stephen Rocamboli | Grant/Award | 4,667 | n/a |
| Apr 22, 2024 | Harlan F. Weisman, President and CEO | Grant/Award | 44,967 | n/a |